Works in Cancer Chemotherapy & Pharmacology, 2024, Vol 93, Issue 6

Results: 12

Using maximum plasma concentration (C<sub>max</sub>) to personalize taxane treatment and reduce toxicity.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 525, doi. 10.1007/s00280-024-04677-1
By:
- Sun, Yuchen;
- Cheng, Yue;
- Hertz, Daniel L.
Publication type:
Article
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 595, doi. 10.1007/s00280-024-04656-6
By:
- Marcelletti, John F.;
- Sikic, Branimir I.
Publication type:
Article
Machine learning application identifies plasma markers for proteinuria in metastatic colorectal cancer patients treated with Bevacizumab.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 587, doi. 10.1007/s00280-024-04655-7
By:
- Yu, Zhuoyuan;
- Xu, Haifan;
- Feng, Miao;
- Chen, Liqun
Publication type:
Article
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 617, doi. 10.1007/s00280-024-04653-9
By:
- Gaietto, Alyssa;
- Panetta, John C;
- Pauley, Jennifer L;
- Relling, Mary V;
- Ribeiro, Raul;
- Ehrhardt, Matthew J;
- Pui, Ching-Hon;
- Inaba, Hiroto;
- Swanson, Hope D
Publication type:
Article
Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 565, doi. 10.1007/s00280-024-04648-6
By:
- Ozawa, Mayumi;
- Watanabe, Jun;
- Ishibe, Atsushi;
- Goto, Koki;
- Fujii, Yoshiro;
- Nakagawa, Kazuya;
- Suwa, Yusuke;
- Suwa, Hirokazu;
- Masui, Hidenobu;
- Sugita, Mitsutaka;
- Mochizuki, Yasuhisa;
- Yamagishi, Shigeru;
- Hasegawa, Seiji;
- Homma, Yuki;
- Momiyama, Masashi;
- Kumamoto, Takafumi;
- Matsuyama, Ryusei;
- Takeda, Kazuhisa;
- Taguri, Masataka;
- Endo, Itaru
Publication type:
Article
18β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 575, doi. 10.1007/s00280-024-04639-7
By:
- Ma, Xuan;
- Sun, Zhenou;
- Chen, Hui;
- Cao, Lixing;
- Zhao, Shuang;
- Fan, Lihong;
- Zhao, Chong;
- Yin, Shutao;
- Hu, Hongbo
Publication type:
Article
Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 555, doi. 10.1007/s00280-023-04637-1
By:
- Jørgensen, Andrea René;
- Bue, Mats;
- Hanberg, Pelle;
- Petersen, Elisabeth Krogsgaard;
- Harlev, Christina;
- Hansen, Jakob;
- Baad-Hansen, Thomas;
- Safwat, Akmal;
- Stilling, Maiken
Publication type:
Article
A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 605, doi. 10.1007/s00280-023-04631-7
By:
- Doi, Toshihiko;
- Takahashi, Shunji;
- Aoki, Daisuke;
- Yonemori, Kan;
- Hara, Hiroki;
- Hasegawa, Kosei;
- Takehara, Kazuhiro;
- Harano, Kenichi;
- Yunokawa, Mayu;
- Nomura, Hiroyuki;
- Shimoi, Tatsunori;
- Horie, Koji;
- Ogasawara, Aiko;
- Okame, Shinichi
Publication type:
Article
Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 633, doi. 10.1007/s00280-023-04628-2
By:
- Suzuki, Yoshiharu;
- Ishiguro, Shingo;
- Shimada, Hirokazu;
- Ohgami, Masahiro;
- Suzuki, Mika
Publication type:
Article
Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer patients; a prospective clinical study.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 541, doi. 10.1007/s00280-023-04620-w
By:
- ELKasar, Ahmed O.;
- Hussien, Fatma Z.;
- Abdel-Hamied, Hala E.;
- Saleh, Ibrahim G.;
- Mahgoup, Elsayed M.;
- El-Arabey, Amr A.;
- Abd-Allah, Adel R.
Publication type:
Article
Azithromycin in cancer treatment: envisioning the probable link of mitochondrial dysfunction and necroptosis.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 639, doi. 10.1007/s00280-023-04617-5
By:
- Hassan, Siti Nazihahasma;
- Ahmad, Farizan
Publication type:
Article
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 627, doi. 10.1007/s00280-023-04611-x
By:
- Hamimed, Mourad;
- Devillier, Raynier;
- Weiller, Pierre-Jean;
- Marin, Clémence;
- Schiano, Jean-Marc;
- Belmecheri, Nawel;
- Etienne-Grimaldi, Marie-Christine;
- Ciccolini, Joseph;
- Harbi, Samia
Publication type:
Article